Shopping Cart
- Remove All
- Your shopping cart is currently empty
MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) is a strychnine-insensitive modulatory site of the NMDA receptor (glycineB)antagonist with Ki of 33 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $88 | In Stock | |
5 mg | $213 | In Stock | |
10 mg | $347 | In Stock | |
25 mg | $689 | In Stock | |
50 mg | $1,160 | In Stock | |
100 mg | $1,560 | In Stock | |
1 mL x 10 mM (in DMSO) | $235 | In Stock |
Description | MRZ 2-514 (8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one) is a strychnine-insensitive modulatory site of the NMDA receptor (glycineB)antagonist with Ki of 33 μM. |
Targets&IC50 | NMDA:33 μM (Ki), AMPA:72.7 μM |
In vitro | MRZ 2-514 against peak AMPA-induced currents with IC50 values of 72.7 μM[1]. |
In vivo | In mice, MRZ 2-514 has anticonvulsive action in the MES model, and the effect is prolonged by probenecid[1]. |
Alias | 8-bromo-4,5-dihydroxypyridazino[4,5-b]quinolin-1-one |
Molecular Weight | 308.09 |
Formula | C11H6BrN3O3 |
Cas No. | 202808-11-5 |
Smiles | [O-][n+]1c2ccc(Br)cc2cc2c1c(=O)[nH][nH]c2=O |
Relative Density. | 2.07 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 18.33 mg/ml (59.51 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.